203302-97-0

203302-97-0 - Names and Identifiers

Name	3-(trifluoromethoxy)phenylacetic acid
Synonyms	RARECHEM AL BO 0629 Room trifluoromethoxy acid Trifluoromethoxyphenylaceticacid methyl henicosafluoroundecanoate 3-Trifluoromethoxyphenylacetic acid 3-Trifluoromethoxyphenylacetic Acid 3-(trifluoromethoxy)phenylacetic acid 3-(TRIFLUOROMETHOXY)PHENYLACETIC ACID 3-(Trifluoromethoxy)benzeneacetic acid 2-(3-(trifluoromethoxy)phenyl)acetic acid 2-[3-(trifluoromethoxy)phenyl]ethanoic acid
CAS	203302-97-0
EINECS	642-512-2
InChI	InChI=1/C9H7F3O3/c10-9(11,12)15-7-3-1-2-6(4-7)5-8(13)14/h1-4H,5H2,(H,13,14)

203302-97-0 - Physico-chemical Properties

Molecular Formula	C9H7F3O3
Molar Mass	220.15
Density	1.399±0.06 g/cm3(Predicted)
Melting Point	53-55°C
Boling Point	260.2±35.0 °C(Predicted)
Flash Point	111.2°C
Vapor Presure	0.00632mmHg at 25°C
pKa	4.10±0.10(Predicted)
Storage Condition	Sealed in dry,Room Temperature
Refractive Index	1.477
MDL	MFCD00082480

203302-97-0 - Risk and Safety

Hazard Symbols	Xi - Irritant
Risk Codes	R36/37/38 - Irritating to eyes, respiratory system and skin. R36 - Irritating to the eyes
Safety Description	S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S37 - Wear suitable gloves.
HS Code	29189900
Hazard Class	IRRITANT

203302-97-0 - Reference Information

Introduction

3-trifluoromethoxyphenylacetic acid is an organic intermediate useful in the preparation of analgesic compounds and glutaminase inhibitors.

Application

3-trifluoromethoxyphenylacetic acid can be used to prepare 3-(dimethylaminomethyl) with the following structure piperidin-4-ol derivatives. The compounds are useful in the treatment or amelioration of diseases associated with opioid receptors. The disease may be selected from, but not limited to, pain, gastrointestinal disorders, and depression. For example, the pain may be selected from, but not limited to, centrally mediated pain, peripherally mediated pain, pain associated with structural or soft tissue injury, pain associated with inflammation, pain associated with progressive disease, neuropathic pain, acute pain and chronic pain.

Last Update：2024-04-09 21:01:54